Clinical development success rates for investigational drugs

Nat Biotechnol. 2014 Jan;32(1):40-51. doi: 10.1038/nbt.2786.

Authors

Michael Hay¹, David W Thomas², John L Craighead³, Celia Economides², Jesse Rosenthal¹

Affiliations

¹ BioMedTracker, Sagient Research Systems, San Diego, California, USA.
² Biotechnology Industry Organization (BIO), Washington, DC, USA.
³ Biotech Strategy & Analytics, Rockville, Maryland, USA.

PMID: 24406927
DOI: 10.1038/nbt.2786

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biomedical Research
Drug Approval / legislation & jurisprudence*
Drugs, Investigational / therapeutic use*
Humans
United States
United States Food and Drug Administration / legislation & jurisprudence

Substances

Drugs, Investigational